NCT02328729

Brief Summary

Incident and extent of pulse alteration during administration of various modes of local anesthesia in children during routine dental treatment. Our aims are: (1) To estimate the percent of patients who receive mandibular block , C-CLAD-IL or infiltration injections and show increase in their pulse rate during the delivery of anesthesia (in spite of negative aspiration) as result of infiltration of adrenalin into their blood vessels. (2) To estimate the extent of pulse rate alteration in correlation with the velocity or volume of local anesthesia injected. (3) To examine the correlation between increase in the pulse rate and effectiveness of anesthesia. (4) To examine the correlation between the needle gauge (27 \& 30) and increase in pulse rate during mandibular block injection in spite of negative aspiration. We will recruit children that undergo routine dental treatment under local anesthesia (such as mandibular block, infiltration or C-CLAD-IL). Patients will be connected, immediately before and during the entire delivery of the local anesthetic, to pulse-oximeter that will be connected to a computer and continuously monitor pulse rate and saturation during the delivery of local anesthesia. Each aberrant event which may occur during alteration of the pulse rate such as gag reflex, coughing, or pain related disruptive behavior will be documented on the computer in real time by another person that is not the treating dentist. All types of local anesthesia delivery will be performed by the computerized-controlled local anesthesia delivery system - Single-Tooth-Anesthesia which connected to a computer and documents continuously the amount and velocity of the local anesthetic delivered to the patient. All injections will be performed by using a 29 gauge needle, except when children will be treated under general anesthesia, the injection will be performed also by 27 gauge needle. In case the pulse rate will increase to 150% of the baseline rate, or when the pulse will reach 150 beats/minute the injection will be stopped immediately. The continuation of the local anesthetic delivery will be continued in different location and only after the return of the pulse to its basic rate. A total of 100 patients will receive local anesthetic containing 1:100,000 adrenalin and 50 patients without adrenaline. Three modes of local anesthesia will be evaluated: C-CLAD-IL, infiltration and mandibular block= a total of 300 patients.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2015

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 25, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 31, 2014

Completed
1 day until next milestone

Study Start

First participant enrolled

January 1, 2015

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2016

Completed
Last Updated

December 31, 2014

Status Verified

December 1, 2014

Enrollment Period

11 months

First QC Date

December 25, 2014

Last Update Submit

December 25, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pulse rate alteration (1-90 beates)

    increase pulse rate above 50% of the baseline rate, or when the pulse will reach 150 beats/minute the injection will be stopped immediately.

    10 minutes, during entire delivery of local anesthesia

Study Arms (6)

Mandibular block with Epinephrine

Lidocaine 2% with 1:100,000 Epinephrine

Procedure: mandibular block with Epinephrine

C-CLAD-IL with Epinephrine

Lidocaine 2% and 1:100,000 Epinephrine

Procedure: C-CLAD-IL with Epinephrine

Infiltration with Epinephrine

Lidocaine 2% and 1:100,000 Epinephrine

Procedure: Infiltration with Epinephrine

Mandibular block without Epinephrine

Mepivacain HCl 3% without Epinephrine

Procedure: Mandibular block without Epinephrine

Infiltration without Epinephrine

Mepivacain 3% without Epinephrine

Procedure: nfiltration without Epinephrine

CCLAD-IL without Epinephrine

Mepivacain HCl 3% without Epinephrine

Procedure: C-CLAD-IL without Epinephrine

Interventions

Delivery of mandibular block anesthesia for dental treatment with Lidocaine HCl 2% with 1:100,000 Epineprine

Mandibular block with Epinephrine

Delivery of C-CLAD-ILanesthesia for dental treatment with Lidocaine HCl 2% with 1:100,000 Epineprine

C-CLAD-IL with Epinephrine

Delivery of infiltration anesthesia for dental treatment with Lidocaine HCl 2% with 1:100,000 Epineprine

Infiltration with Epinephrine

Delivery of mandibular block anesthesia for dental treatment with Mepivacaine 3% without Epineprine

Mandibular block without Epinephrine

Delivery of C-CLAD-ILanesthesia for dental treatment with Mepivacaine 3% without Epineprine

CCLAD-IL without Epinephrine

Delivery of infiltration anesthesia for dental treatment with Mepivacaine 3% without Epineprine

Infiltration without Epinephrine

Eligibility Criteria

Age2 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Children undergo routine dental treatment that require local anesthetic.

You may qualify if:

  • All children that their parents signed the inform consent form and the children allow to put the pulse oximeter sensor on their finger/ear.

You may not qualify if:

  • Children that does not allow to put the pulse oximeter sensor on their finger/ear.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Tachycardia

Interventions

Epinephrine

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesCardiac Conduction System DiseasePathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

EthanolaminesAmino AlcoholsAlcoholsOrganic ChemicalsAminesBiogenic MonoaminesBiogenic AminesCatecholaminesCatecholsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbons

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

December 25, 2014

First Posted

December 31, 2014

Study Start

January 1, 2015

Primary Completion

December 1, 2015

Study Completion

January 1, 2016

Last Updated

December 31, 2014

Record last verified: 2014-12